about
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticlesPolyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.Size analysis of submicron particles by laser diffractometry--90% of the published measurements are false.Development of an oral rutin nanocrystal formulation.Kinetic solubility and dissolution velocity of rutin nanocrystals.Production and characterization of Hesperetin nanosuspensions for dermal delivery.Particle size analysis of nanocrystals: improved analysis method.Development of curcumin nanocrystal: physical aspects.Ultra-small lipid nanoparticles promote the penetration of coenzyme Q10 in skin cells and counteract oxidative stress.Static image analysis as new approach for the characterization of tumor cell lysate used in dendritic cell vaccine preparationAmorphous cyclosporin A nanoparticles for enhanced dermal bioavailability.Destabilization Mechanism of Ionic Surfactant on Curcumin Nanocrystal against Electrolytes.Determination of nanostructures and drug distribution in lipid nanoparticles by single molecule microscopy.Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.Turning Waste into Value: Nanosized Natural Plant Materials of Solanum incanum L. and Pterocarpus erinaceus Poir with Promising Antimicrobial Activities.State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems.Development of cationic nanocrystals for ocular delivery.A new concept for the treatment of atopic dermatitis: silver-nanolipid complex (sNLC).Dermal miconazole nitrate nanocrystals - formulation development, increased antifungal efficacy & skin penetration.Simple low-cost miniaturization approach for pharmaceutical nanocrystals production.Industrial concentrates of dermal hesperidin smartCrystals®--production, characterization & long-term stability.CapsMorph® technology for oral delivery--theory, preparation and characterization.Protein Adsorption Patterns and Analysis on IV Nanoemulsions-The Key Factor Determining the Organ Distribution.Preservation of nanostructured lipid carriers (NLC).Nanostructured lipid carriers as nitroxide depot system measured by electron paramagnetic resonance spectroscopy.Ultra-small NLC for improved dermal delivery of coenyzme Q10.ROS production and glutathione response in keratinocytes after application of β-carotene and VIS/NIR irradiation.Resuspendable Powders of Lyophilized Chalcogen Particles with Activity against Microorganisms.No time to waste organic waste: Nanosizing converts remains of food processing into refined materials.Natural Nanoparticles: A Particular Matter Inspired by Nature.Oral hesperidin-Amorphization and improved dissolution properties by controlled loading onto porous silica.Preparation and tableting of long-term stable amorphous rutin using porous silica.Solidification of hesperidin nanosuspension by spray drying optimized by design of experiment (DoE).Dermal nanocrystals from medium soluble actives - physical stability and stability affecting parameters.Nanocrystals of medium soluble actives--novel concept for improved dermal delivery and production strategy.Pharmaceutical nanoparticles--from their innovative origin to their future.Outcomes of pneumatic dilation in achalasia: extended follow-up of more than 25 years with a focus on manometric subtypes.Natural selenium particles from Staphylococcus carnosus: Hazards or particles with particular promise?Time to rethink filtration.
P50
Q28283289-85FE1D2D-A7B1-4E62-A67F-60C982E20D18Q30995632-C6CBB04D-A070-4535-B341-0B826FA5A9B0Q33315203-5C8C33DD-B270-4BF9-B11C-A9C89D7E1D16Q33396383-3410B41B-F410-424C-B3E6-10B2D30E57E1Q33398423-6EC5C026-83CF-4406-9A08-A9BC88609DCEQ33402012-3D84D492-4E03-4C1F-A786-CA9E578469B4Q33500482-98982C61-F8F2-47F1-94B0-1A28AF305F9BQ34437322-DFCBA4F2-5B6A-4B46-B97D-AE824DB17495Q35513382-8D587CEF-B9A4-4F97-8230-51AC33D096B0Q35631287-CF4B6A7A-A8DE-4651-A330-022E95F25C26Q35873900-6B64E48A-98DC-47AE-9C6B-F4D704C4C2ECQ36168893-4DBEF916-A23A-4DEF-A8B5-1ADEC48FCB1CQ36181728-8DD614DC-4219-4CCE-8A16-C96CD84A13C4Q36243834-189EB288-B71E-48FD-82E5-5E655E2E7F1EQ37063880-989112C2-8764-48D6-9B57-ED6B139FBB66Q37832314-46120DF6-F4CC-4696-BBD4-6E50604534BBQ38075334-8A6DA230-A8CB-4BFC-AB32-FC9B9297E5FDQ38759300-1DE9538B-95BD-4B4A-9E03-7BF1DF218D18Q39282450-A477A6E8-F2C7-4FF1-8A70-5540783BB8A0Q40074172-E5BD1B2D-C0C7-414A-9424-A8527A8B5FC3Q40237050-8CFD589A-0CA1-4260-9E75-F2F19F72F155Q41757373-12C837A8-BFDA-4783-919E-65FE12F099E8Q41759942-ECB1219D-5560-4C45-BF96-1F96B95D2815Q42271492-0678AB03-B8D9-41A1-A072-ECCE785B134DQ44447009-80B0A338-2ABF-40A9-9AEC-FE8DD80113A7Q45963360-A15EC5C3-A3EF-4D6E-BF3A-16C6282BDBA4Q46123322-3EE0D3B5-DF10-4940-9488-058CB3F44AC9Q46248448-08811FE1-B5F8-40C1-8897-F0F71963EE29Q47695603-544A27E4-48AC-4C1E-A856-669641916033Q47733563-9463ECA1-C81A-41FF-B3E7-0993F5121839Q47759836-D61441AC-6DA2-4903-8033-BABE6827A79CQ47849723-3A876505-DFE8-42A2-9A6A-C24D3049549AQ47850988-17E0A8B2-B598-44E2-AF56-95281A0DAD3AQ47861421-F4F964AA-1DDB-4EA4-BE6A-32EC8B379B83Q47993226-18F11E64-1D83-436B-A15A-AB233D62CCE0Q48004597-71E5A745-136E-4E33-AD47-262D58C7D0EFQ48886577-EFAFE184-3221-445F-99F0-4409A0A66CDEQ49999204-1F3E3E09-91D5-4148-B54D-B77AA0713D68Q50254506-90FFE569-CAC5-412B-8E02-268257510AA3Q51071384-53F30D59-56AC-458C-8C60-C89601ACB9AF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cornelia Keck
@ast
Cornelia Keck
@en
Cornelia Keck
@es
Cornelia Keck
@nl
Cornelia Keck
@sl
type
label
Cornelia Keck
@ast
Cornelia Keck
@en
Cornelia Keck
@es
Cornelia Keck
@nl
Cornelia Keck
@sl
prefLabel
Cornelia Keck
@ast
Cornelia Keck
@en
Cornelia Keck
@es
Cornelia Keck
@nl
Cornelia Keck
@sl
P106
P21
P31
P496
0000-0001-8888-2340